Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins eHealth Radio and the Health News and Cancer Information Channels.
Listen to interview with host Eric Michaels and guest Dr. Jose E. Vidal discuss the following:
In conclusion, cell therapy is the next significant step in fighting hard to treat cancer and autoimmune conditions. It has been proven to provide results superior to any treatment seen before. Now, we are working on improving access for patients by optimizing the manufacturing process and lowering therapy cost.
Dr. Jose Eduardo Vidal obtained his doctoral degree in Cellular and Molecular Biology from the University of Puerto Rico. He started his career in the pharmaceutical industry in Wyeth as a process development scientist working with small molecules and the first Biologics development pipeline upon the acquisition of Immunex.
With Wyeth he worked on the development and commercial launch of Mylotarg (very first ADC). He continued to develop as a biopharmaceutical professional occupying positions of increased responsibility in Tech Services, Process Development and Quality. After 10 years with the company and managing 14 sites world wide Jose joined Amgen as the head of Process Development. With Amgen Jose managed the biologics new product development with over one hundred programs in the pipeline. Jose also managed the drug substance manufacturing organization as the VP of operations and also lead the global late stage product pipeline as the global VP of Process Development where he got acquainted with Cell and Gene therapy.
In 2018 Jose joined Atara where he led the company as SVP of Process Development and Global Quality to develop and submit for commercial licensing the first ever Allogeneic TCell therapy product (Ebvallo) which was approved for commercial distribution in Dec 2022. He also successfully designed and led the development of TCell therapy manufacturing process in stirred tank, perfusion bioreactors.
Lately Jose joined Cytoimmune Therapeutics as the Chief Operations Officer and has been working in starting up the company and the operation from the ground up with operations in PR. Cytoimmune is focused in developing oncology and autoimmune malignancies therapies based on Allogeneic NK-CAR cells.
Jose has also worked with other operations and startups as Pfizer and Biovail and has served as advisor for multiple biotechnology startups with 25 years in the industry in which he has achieved taking from RnD to market more than 200 products/therapies and has pioneered the evolution of therapies from chemical synthesis, biologics to cell and gene therapy. Jose is an early adopter and champion of real time predictive statistical modeling and deep machine learning.
Website: https://www.cytoimmune.com
Social Media Links:
Linkedin: https://www.linkedin.com/company/cytoimmune-therapeutics
Twitter: @CytoImmune
People also listened to this: A Breakthrough Solution for Treating Central Nervous System Disorders Including Strokes and Cluster Headaches
The Benefits of Genetic Counseling during Pregnancy
Is the world ready for genome screening of IVF embryos for every genetic disease?
Reproductive and Prostate health with Dr. Justin Houman
How To Manage Your Dog’s Anxiety
Virtual Family Behavioral Health: Digital care solutions that help working parents, children and teenagers get the support they need
The Toxic Overload with Dr. Kourosh Maddahi
It’s Time to Abolish the Idea that Being Tough on Young People Improves Performance
Plastic Free July with Organic and Plastic Free Natracare Founder Susie Hewson
Virtual Care Solution to Support Behavioral Health Care in Post-Pandemic Era
Two Founders of Female Physician Leadership Council Address Gender Parity in Health Care
Yumble, the only kids meal delivery service
Why trauma often leads to people sabotaging their relationships with Orit Krug
Scalar Energy Healing with Tom Paladino
A People’s Guide to End of Life with Dr. Joseph Layon
Torque3 Launches Alpha Program to Evaluate Equipment Designed to Reinvent Stroke Rehabilitation
AscellaHealth’s Craig Caceci, Executive Vice President and Managing Director, Terebellum
What Cats Are Really Into and How To Keep Them Well Trained
Hair Loss in men and women with Dr. Nettles
Proven Steps for Deep Restful Sleep & Avoid Sleepless Nights for Good
Global Game Changers Shares 6 Emotion Management Tips for Kids
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive